Patient involvement in medicines development and approvals New winds are blowing across Europe towards a paradigm shift of having patients much more actively involved in medicines research and development. There is a growing awareness that involvement of the patients in both development and approval of new medicines is crucial to secure medicines of value. Regulatory agencies and industry have the obligation to secure the norms and standards of quality, safety and efficacy are fulfilled. Patients, however, may have a different view on what is considered to be acceptable. Hence, academic institutions, regulatory agencies and the pharmaceutical industry are seeking to develop methodologies securing patient involvement in development and approvals of new medicines and new use of approved medicines. The aims of this workshop are to establish a common platform/understanding and provide inspiration for future initiatives within Regulatory Science on benefit-risk decisions having patient involvement and perspectives as a key feature. Link to full program Location: Universitetsparken 2, 2100 Copenhagen Date: 6th of May Time: 09:30 - 16:00 Link to map showing entrance Please register here. Note that you need to press "Send values" in order to register. You will receive a confirmation e-mail A no show fee of 500 DKK will be charged upon not showing up without cancelation Biopeople contact: Niels Westergaard Faculty of Health and Medical Sciences contact: Karin Friis Bach at karin.bach@sund.ku.dk.